findmyKOL
Clinical trialNCT02502409UnknownObservational

Natural History Study of Factor IX Treatment and Complications

SponsorSkane University HospitalEnrollment550Factor IX Deficiency
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Alice J. Cohen, MD

    Newark Beth Israel Medical Center, Newark, NJ

    Principal Investigator
  • Amy D Shapiro, MD

    Indiana Hemophilia &Thrombosis Center, Inc.

    Study Director
  • Catherine McGuinn, MD

    Weill Cornell Medical College, New York, NY

    Principal Investigator
  • Christine Kempton, MD

    Emory University, Atlanta, Georgia

    Principal Investigator
  • Christine Knoll, MD

    Phoenix Children's Hospital, Phoenix, AZ

    Principal Investigator
  • Christoph Bidlingmaier, MD

    Dr. v Hauner Children's University Hospital, Munich, Germany

    Principal Investigator
  • Cristina Tarango, MD

    Cincinnati Children's Hospital Medical Center, Cincinnati, OH US

    Principal Investigator
  • Erik Berntorp, MD, PhD

    Skåne University Hospital, Malmö

    Study Director
  • Eva Funding, MD

    National University Hospital Copenhagen, Copenhagen, Denmark

    Principal Investigator
  • Jan Astermark, MD, PhD

    Skåne University Hospital, Malmö

    Study Director
  • Johannes Oldenburg, MD, Ph.D

    University Clinic, Bonn

    Principal Investigator
  • Katharina Holstein, MD

    University Medical Centre Hamburg-Eppendorf, Hamburg, Germany

    Principal Investigator
  • Manuela Carvalho, MD

    Centro Hospitalar de São João, Porto, Portugal

    Principal Investigator
  • Margaret Ragni, MD

    University of Pittsburgh and Hemophilia Center of Western Pennsylvania, Pittburgh, PA US

    Principal Investigator
  • Michael D Tarantino, MD

    Bleeding and Clotting Disorders Institute, Peoria, IL US

    Principal Investigator
  • Michelle Witkop, DNP, FNP-BC

    Munson Medical Center, Traverse City, MI, US

    Principal Investigator
  • Munira Borhany, MD

    National Institute of Blood Disease and Bone Marrow Transplantation, Karachi, Pakistan

    Principal Investigator
  • Philip Kuriakose, MD

    Henry Ford Health System, Detroit, MI

    Principal Investigator
  • Raina Liesner, MD

    Great Ormond Street Hospital for Children, London, UK

    Principal Investigator
  • Roshni Kulkarni, MD

    Michigan State University, East Lansing, MI

    Principal Investigator
  • Stacy Croteau, MD

    Boston Hemophilia Center, Boston, MA

    Principal Investigator
  • Suchitra Acharya, MD

    Cohen Children's Medical Center, New Hyde Park, NY

    Principal Investigator
  • Susan Kearney, MD

    Children's Hospitals and Clinics of Minnesota, Minneapolis, MN

    Principal Investigator
  • Ulrike Reiss, MD

    St. Jude Children's Research Hospital, Memphis, TN US

    Principal Investigator
  • Yasmina Abajas, MD

    University of North Carolina Hemophilia Treatment Center, Chapel Hill, NC

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Indiana Hemophilia & Thrombosis Center

    Indianapolis, Indiana, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2015
Primary completion
30 Jun 2019
Completion
31 Dec 2021
Last update posted
25 May 2021
Registered enrollment
550
Registry id
NCT02502409

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.